Advances in HIV therapeutics. A report from the 2017 Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, Washington, USA - February 13-16, 2017

Autor:	Zelalem Temesgen, W. El Atrouni, Stacey A. Rizza, Ramona Bhatia
Rok vydání:	2017
Předmět:	Pharmacology Ibalizumab Bictegravir business.industry Dapivirine Human immunodeficiency virus (HIV) medicine.disease_cause Virology Romidepsin chemistry.chemical_compound Cabotegravir chemistry PRO 140 Doravirine Immunology medicine Pharmacology (medical) business medicine.drug
Zdroj:	Drugs of the Future. 42:241
ISSN:	0377-8282
DOI:	10.1358/dof.2017.042.04.2625317
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::78cb2b224e52c9b1c7963dd26fc9ac5c https://doi.org/10.1358/dof.2017.042.04.2625317 Zobrazit plný text záznamu